CIK: 1229447 - Address: C/o Codexis, Inc., 200 Penobscot Drive, Redwood City, CA 94063
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111-151-21-40-23-13
S%wins1000010010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/15/20 12:09
12/11/20
FPRXFive Prime Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSmith David VCAOEVP,CFOM.d00.000223978D
11/13/20 12:29
11/11/20
FPRXFive Prime Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSmith David VCAOEVP,CFOM.d00.000224274D
4/5/18 13:11
4/3/18
CDXSCodexis IncChemOChmIndustrial Organic ChemicalsSmith David VCADS-6210.370-6-1057I
5/24/16 13:19
5/20/16
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSmith David VWADM.d00.00133610D-76-51-614820-128-1081114-36-46
5/22/15 09:34
5/20/15
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSmith David VWADM.d00.0003567D-82-49-12-17-21-461-212483223-53
6/9/14 12:50
6/5/14
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSmith David VWADM.d00.00131255D-72-65-56-72-64-9-1531-5-3-11-35-25
5/28/13 12:34
5/23/13
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSmith David VWADM.d2110.6412New2D-32-17-10-103363-1-4-12-14-25-64
6/7/10 17:01
6/3/10
THORThoratec CorpCAHealthElcMdElectromedical & ElectrotheraSmith David VCAOCFO,EVPM.d52717.58333010658D14871383425420-151-21-40-23
6/7/10 17:01
6/3/10
THORThoratec CorpCAHealthElcMdElectromedical & ElectrotheraSmith David VCAOCFO,EVPS.d-1,33144.3733-30-3458D14871383425420-151-21-40-23

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact